Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Master's Award: Canada Graduate Scholarships

University of British Columbia

$17,500.00

Effects of Previous Coronavirus Infections on the Immune Response to SARS-CoV-2 Infection

FY 2020-21

Summary
COVID-19 is caused by SARS-CoV-2, which has infected over 56 million people globally since its emergence in late 2019, causing profound disruptions in our daily lives. It is a member of the coronavirus family, which also houses a group of viruses called HCoVs that are responsible for the common cold. The surface of a virus is unique like a fingerprint. The adaptive immune system designs antibodies that will specifically recognize and attach to patterns on a particular virus to fight the infection. This response is then saved into the immune system's memory so that the next time the fingerprint is seen, antibodies can be released nearly immediately. This response forms the basis of vaccinations. But what happens when a new virus' fingerprint is very similar to a previously encountered one's? This is often the case for the flu, where the vaccine changes almost yearly because the virus is constantly mutating. If a flu shot contains a similar enough fingerprint to a previously encountered virus, the individual develops a strengthened response to the earlier virus and no response and no protection against the one in the vaccine. This is known as the original antigenic sin (OAS) and describes how our immune system prefers to use immune memory whenever possible. We believe the severe symptoms seen in COVID-19 are a result of OAS generating an excess of antibodies directed against HCoVs rather than SARS-CoV-2 as they are very similar. Our study aims to use antibody tests to identify the antibodies generated throughout the course of SARS-CoV-2 infection to determine if OAS results in worse COVID-19 outcomes. Our findings will not only help identify those at highest risk for severe symptoms, but will also provide insight for COVID-19 vaccination strategies.
Program
Master's Award: Canada Graduate Scholarships
Location
British Columbia, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
449618
Name
Li Fang Fang
Region
British Columbia
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Effects of Previous Coronavirus Infections on the Immune Response to SARS-CoV-2 Infection
Programtype2
Studentship Programs
Orgnameinp2
University of British Columbia
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Anamnestic Response; Antibodies; Clinical Outcomes; Covid-19; Cross-Reactivity; Immune Memory; Original Antigenic Sin; Sars-Cov-2; Sequencing; Serology
Abstract
COVID-19 is caused by SARS-CoV-2, which has infected over 56 million people globally since its emergence in late 2019, causing profound disruptions in our daily lives. It is a member of the coronavirus family, which also houses a group of viruses called HCoVs that are responsible for the common cold. The surface of a virus is unique like a fingerprint. The adaptive immune system designs antibodies that will specifically recognize and attach to patterns on a particular virus to fight the infection. This response is then saved into the immune system's memory so that the next time the fingerprint is seen, antibodies can be released nearly immediately. This response forms the basis of vaccinations. But what happens when a new virus' fingerprint is very similar to a previously encountered one's? This is often the case for the flu, where the vaccine changes almost yearly because the virus is constantly mutating. If a flu shot contains a similar enough fingerprint to a previously encountered virus, the individual develops a strengthened response to the earlier virus and no response and no protection against the one in the vaccine. This is known as the original antigenic sin (OAS) and describes how our immune system prefers to use immune memory whenever possible. We believe the severe symptoms seen in COVID-19 are a result of OAS generating an excess of antibodies directed against HCoVs rather than SARS-CoV-2 as they are very similar. Our study aims to use antibody tests to identify the antibodies generated throughout the course of SARS-CoV-2 infection to determine if OAS results in worse COVID-19 outcomes. Our findings will not only help identify those at highest risk for severe symptoms, but will also provide insight for COVID-19 vaccination strategies.
Competitiondate
202012
Approvedterm2
1 yr 0 mth
Pinamesdelim
Li, Fang Fang
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~